AI-guided kidney tumor surgery study
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a kidney tumor that can be treated with surgery
- You had a contrast-enhanced CT scan of your abdomen within 30 days before surgery
- You understand the study and agree to participate by signing a consent form
- Your medical records have complete information about your diagnosis and health history
- The tumor has not spread to other parts of the body when it was found
- You have not had any previous treatment for this tumor, such as surgery, targeted therapy, or immunotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
This trial uses a special computer model to predict how well your kidneys will work after surgery to remove part of a kidney (partial nephrectomy). It may help doctors plan better care for people with early-stage kidney tumors.
This trial uses artificial intelligence (AI) to analyze standard, non-contrast CT scans to identify and understand kidney tumors. It aims to help doctors make better decisions without needing special dye injections.
This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
This trial tests an artificial intelligence system that helps doctors analyze kidney tissue samples. If you have chronic kidney disease and need a biopsy, this study will see if the AI can improve diagnosis.
Hear when a new Pathology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.